LoginGet started
Picture of Suven Life Sciences logo

SUVEN — Suven Life Sciences Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for Suven Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
C2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS		—
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue144135118135117
Cost of Revenue
Gross Profit128134117132—
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,3419751,3451,3951,387
Operating Profit-1,197-840-1,226-1,260-1,271
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1,064-775-1,220-1,183-1,061
Provision for Income Taxes
Net Income After Taxes-942-722-1,220-1,183-1,051
Net Income Before Extraordinary Items
Net Income-942-722-1,220-1,183-1,051
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-942-722-1,220-1,183-1,051
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-6.82-5.22-9.32-6.97-5.04